MoneyWorks4Me

Lactose India - Quaterly Results

02 Nov 2023 Evaluate
The topline stands at Rs. 244.26 millions for the September 2023 quarter. The mentioned figure indicates a rise of about 85.50% as against Rs. 131.68 millions during the year-ago period.Net Profit for the quarter ended September 2023 zoomed to 826.44% from Rs. 0.87 millions to Rs. 8.06  millions.Operating Profit saw a handsome growth to 36.52 millions from 25.56 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 244.26 131.68 85.50 518.93 227.92 127.68 657.96 459.39 43.22
Other Income 2.57 1.99 29.15 5.38 4.24 26.89 7.29 5.79 25.91
PBIDT 36.52 25.56 42.88 77.02 50.64 52.09 121.85 128.40 -5.10
Interest 13.14 13.15 -0.08 28.66 25.56 12.13 60.36 51.16 17.98
PBDT 23.38 12.41 88.40 48.36 25.08 92.82 61.49 77.24 -20.39
Depreciation 11.98 11.67 2.66 23.89 23.27 2.66 46.85 45.59 2.76
PBT 11.40 0.74 1440.54 24.47 1.81 1251.93 14.64 31.65 -53.74
TAX 3.34 -0.13 -2669.23 6.84 0.07 9671.43 2.56 7.16 -64.25
Deferred Tax 1.42 0.38 273.68 2.74 0.48 470.83 0.77 1.46 -47.26
PAT 8.06 0.87 826.44 17.63 1.74 913.22 12.08 24.49 -50.67
Equity 125.89 125.89 0.00 125.89 125.89 0.00 125.89 125.89 0.00
PBIDTM(%) 14.95 19.41 -22.97 14.84 22.22 -33.20 18.52 27.95 -33.74
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..